QURE
#1851
uniQure N.V. - Ordinary Shares
39.4 8 USD
-0.02%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-2.23%
Variación mensual
-20.72%
Variación en los últimos 6 meses
+61.14%
Cambio anual
+156.86%
Cierres anteriores
40.3 8
Open
39.6 5
Mínimo
39.2 3
High
39.6 6
Volumen
359
Financials
- Market Capitalization 2.49 B
- Employee 221
- Founded 1998
- CEO Matt Kapusta
- Website www.uniqure.com
- Headquarter Netherlands
- FIGI UNKNOWN
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-4.68
Relación precio/flujo de caja
52.26
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1842 |  IMNM Immunome, Inc. - Common Stock | 21.99 USD | -3.89% | -0.95% | +12.60% | +92.39% | 2.49 B USD | ||
| 1843 |  TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 58.54 USD | +1.67% | +1.47% | -11.84% | -11.38% | 2.52 B USD | ||
| 1852 |  NRIX Nurix Therapeutics, Inc. - Common stock | 23.75 USD | +0.64% | +2.95% | +24.41% | +111.86% | 2.46 B USD | ||
| 1855 |  TRVI Trevi Therapeutics, Inc. - Common Stock | 17.17 USD | -1.09% | -1.09% | -1.66% | +119.57% | 2.44 B USD |